The Price on the Vial
UNICEF and Gavi cut the RTS,S malaria vaccine price by about 40 percent, to 5.50 euros a dose, from 2027 if a new factory is prequalified. The saving could cover up to one million more children.
A malaria vaccine gets 40 percent cheaper. The new price starts in 2027, if a factory clears.
On 22 October 2026, UNICEF and Gavi said they had cut the price of the RTS,S/AS01 malaria vaccine by about 40 percent, to 5.50 euros a dose.
The saving is put at about 50 million dollars between 2027 and 2029. Spent on this vaccine, Gavi says that could buy a full four-dose course for up to one million more children. Spent elsewhere, it could buy other vaccines. The sentence is "up to." It is not a roster.
The lower price is expected in early 2027. It is not the price today. The agreement waits on regulatory and manufacturing milestones, including World Health Organization prequalification of a new factory that is supposed to add supply. An advance payment from the International Finance Facility for Immunisation is what let UNICEF lock the number.
The vaccine is already moving. UNICEF has procured and delivered more than 74 million doses since rollout began in 2024. It is in routine immunisation in 25 African countries that carry more than 70 percent of the world's malaria. Four doses, given seasonally where transmission is seasonal, cut cases by about 75 percent.
The same release states the 2024 burden: an estimated 282 million cases and 610,000 deaths, up to 95 percent of both in Africa, and about 74 percent of the deaths in children under five. One child dies from malaria every minute, the alliance said. A cheaper vial does not rewind that minute. It changes what a budget can buy next year.
Leila Pakkala, director of UNICEF Supply, called the deal a step toward protecting more children where the vaccine is needed most. An Vermeersch, at Gavi, called it market shaping. Georgina Baker, chair of the finance facility, said the point of the facility was to bring prices down so children are protected sooner.
Sooner, in this contract, means 2027.
Key Facts
- Announced 22 October 2026 by UNICEF and Gavi
- RTS,S/AS01 cut by about 40 percent, to EUR 5.50 a dose
- About 50 million dollars saved from 2027 through 2029
- Up to one million more children with a full four-dose course, if the saving is used that way
- Price expected early 2027, after WHO prequalification of a new factory
- More than 74 million doses already delivered since 2024
- Four seasonal doses: about 75 percent fewer cases where transmission is highly seasonal
- 2024 burden in the same release: 282 million cases, 610,000 deaths
Why This Matters
Malaria vaccines were the scarce object. The science of this one is no longer the news. The price is. A 40 percent cut, tied to a second factory, is how a routine programme stops being a pilot. The children in the "one million" are not vaccinated by the press release.
What We Don't Know Yet
Whether the new factory is prequalified on the timetable. Whether ministries spend the saving on more malaria doses. Whether "up to one million" is close to the number or a ceiling. The case reduction of about 75 percent is for seasonal use in high-transmission settings, not a promise for every district.